Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 29,806 | 60,827 | 16,543 | 155,973 | 24,364 |
| Cost of Goods | 6,809 | 4,238 | 3,126 | 3,266 | 3,078 |
| Gross Profit | 22,997 | 56,589 | 13,417 | 152,707 | 21,286 |
| Operating Expenses | 102,030 | 119,820 | 148,785 | 101,999 | 155,199 |
| Operating Income | -78,224 | -62,993 | -135,242 | 50,974 | -133,835 |
| Interest Expense | 141 | 97 | 110 | 109 | 355 |
| Other Income | 5,199 | -322 | 1,041 | -1,303 | -363 |
| Pre-tax Income | -73,166 | -63,412 | -134,311 | 49,562 | -134,553 |
| Income Tax | 23 | 113 | 110 | 106 | -3 |
| Net Income Continuous | -72,624 | -63,205 | -134,078 | 49,798 | -133,988 |
| Net Income | $-72,624 | $-63,205 | $-134,078 | $49,798 | $-133,988 |
| EPS Basic Total Ops | -19.50 | -17.00 | -36.25 | 13.50 | -36.25 |
| EPS Basic Continuous Ops | -19.42 | -16.98 | -36.08 | 13.44 | -36.30 |
| EPS Diluted Total Ops | -19.50 | -17.00 | -36.25 | 13.50 | -36.25 |
| EPS Diluted Continuous Ops | -19.42 | -16.98 | -36.06 | 13.41 | -36.30 |
| EBITDA(a) | $-74,989 | $-59,481 | $-131,624 | $54,245 | $-128,903 |